ECRM_1170x120_1-10-22

COVID-19

Walgreens rolls out Flu Index for the 2020-2021 flu season

Walgreens rolls out Flu Index for the 2020-2021 flu season

DEERFIELD, Ill. – During National Influenza Vaccination Week, Walgreens has launched the Walgreens Flu Index for the 2020-2021 season to help communities track flu activity in their area and serve as a reminder to get vaccinated against the flu. With COVID-19 cases continuing to surge across the country, health experts are encouraging flu shots to

NPTA launches immunization administration training program

NPTA launches immunization administration training program

HOUSTON — As COVID-19 continues to spread across the United States and vaccine distribution to begin possibly this week, the National Pharmacy Technician Association (NPTA) is announcing the launch of a nationally-recognized pharmacy technician administered immunization training program. Developed under the guidance of the U.S. Department of Health and Human Services (HHS), NPTA’s Immunization Administration

Xlear submits COVID-19 pre-EAU request with FDA regarding use of Xlear Nasal Spray to help in combating SARS-CoV-2

Xlear submits COVID-19 pre-EAU request with FDA regarding use of Xlear Nasal Spray to help in combating SARS-CoV-2

WASHINGTON — Xlear is filing a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA). The Pre-EUA is a first step in seeking authorization of Xlear Nasal Spray as a new hygiene tool to help in combat the SARS-CoV-2 virus, the virus that causes COVID-19. Xlear’s Pre-EUA Request is based on

First Databank updates COVID-19 Medical Supply Guide

First Databank updates COVID-19 Medical Supply Guide

SOUTH SAN FRANCISCO – First Databank (FDB) announced today it is updating its COVID-19 Medical Supply Guide to feature new products that have become available, including SARS-CoV-2 test kits, personal protective equipment (PPE) and disinfectants. More than 1,300 new products across these categories have been added to the FDB COVID-19 Medical Supply Guide, which is available

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19

INDIANAPOLIS — Eli Lilly and Co. and the UnitedHealth Group have announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals. Bamlanivimab recently received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration for the treatment of mild to moderate COVID-19 patients who are at high risk

Cardinal Health report explores impact of COVID-19 on oncologists

Cardinal Health report explores impact of COVID-19 on oncologists

DUBLIN, Ohio — In response to the COVID-19 pandemic, U.S. oncologists have adjusted patient care by embracing telemedicine and switching more patients to oral therapies to limit office visits—but personally, more oncologists may be experiencing burnout due to the loss of face-to-face interactions with patients, according to new research from Cardinal Health Specialty Solutions.  

NACDS lauds Pennsylvania law enhancing patient options for health care access as COVID-19 converges with flu

NACDS lauds Pennsylvania law enhancing patient options for health care access as COVID-19 converges with flu

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today hailed a new law that will increase Pennsylvanians’ access to health care as the COVID-19 pandemic converges with the 2020-2021 flu season. Pennsylvania Governor Tom Wolf (D) on November 30 signed into law legislation (Act 140) sponsored by State Rep. Tony DeLuca (D) that

NRF says pandemic shifts more Black Friday shopping online

NRF says pandemic shifts more Black Friday shopping online

WASHINGTON – Fewer people than usual shopped in stores over the Thanksgiving holiday weekend this year, according to the annual survey released Tuesday by the National Retail Federation and Prosper Insights & Analytics. The number of in-store shoppers on Thanksgiving Day dropped by 55% from last year and those on Black Friday dropped by 37%.

New studies conclude Xlear kills and/or deactivates SARS-CoV-2

New studies conclude Xlear kills and/or deactivates SARS-CoV-2

MIAMI — New in vitro studies, led by renowned authority on respiratory diseases, conclude Xlear nasal spray is “an effective…and replicable means to deactivate SARS-CoV-2…to an undetectable amount of infectious virus.” This conclusion is “validated by two independent sets of experiments, performed by different labs, on different viral strains…” The Virucidal studies were independently funded.  

FIP publishes statement on emerging technologies and pharmacy practice

FIP publishes statement on emerging technologies and pharmacy practice

THE HAGUE — The digital era is radically changing how technology is used, and new technologies are set to have major impacts on how people live and work. How pharmacists and pharmacy organizations can rise to the challenge of these technologies and embrace them is set out in a new Position Statement on emerging technologies

Hy-Vee reinstates reserved shopping hour for high risk shoppers

Hy-Vee reinstates reserved shopping hour for high risk shoppers

WEST DES MOINES, Iowa — Hy-Vee announced today that it is reinstating its reserved shopping hour for customers considered “high risk” in response to the recent increase in COVID-19 cases throughout its eight-state region. The reserved hour will be offered at all Hy-Vee locations from 7 a.m. to 8 a.m., Monday through Friday, and is

Wholesalers will help get vaccines to stores

Wholesalers will help get vaccines to stores

NEW YORK — Cardinal Health Inc. and AmerisourceBergen Corp. will be network administrators in the Federal Pharmacy Partnership Strategy for COVID-19, which will enable independent, small chain and long-term-care pharmacies to participate in the vaccination effort. McKesson Corp., which will be a centralized vaccine distributor, is preparing to carry out the Centers for Disease Control

FDA grants emergency use authorization to Regeneron’s COVID-19 antibody

FDA grants emergency use authorization to Regeneron’s COVID-19 antibody

WASHINGTON — The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease. The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild